Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients

NCT00206518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

167

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Taxotere/Docetaxel
DRUG: Adriamycin/Cytoxan
DRUG: doxorubicin

Sponsor

Mothaffar Rimawi

Collaborators

[object Object]